The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...
Approval is based on results from the TROPION-Breast01 Phase III trial, in which Datroway demonstrated a significant reduction in the risk of disease progression or death in patients with previously ...
On January 6, 2025, the FDA released final guidance for industry entitled “Communications From Firms to Health Care Providers Regarding ...
The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...
The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought ...
Approval is based on data from the Phase III CodeBreaK 300 trial, which demonstrated that treatment with Lumakras and ...
These initiatives represent a way to accelerate access to treatments that have historically faced longer regulatory pathways.
More than one-third of websites selling their own versions implied the products were the same as the FDA-approved drugs.
After reviewing the scientific evidence, the agency has decided 20 ZYN nicotine pouch products can legally be sold in the US.
The approval of Calquence marks the first and only BTK inhibitor approved for the first-line treatment of MCL in the US.
Irish neurotech company CergenX has received the Breakthrough Device Designation from the US FDA while being accepted into ...
Tokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the ...